CYTEIR THERAPEUTICS INC has a total of 28 patent applications. Its first patent ever was published in 2018. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are REVIRAL LTD, CHONGQING FOCHON PHARMACEUTICAL CO LTD and ZAFGEN INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | WIPO (World Intellectual Property Organization) | 5 | |
#3 | Australia | 2 | |
#4 | Canada | 2 | |
#5 | China | 2 | |
#6 | EPO (European Patent Office) | 2 | |
#7 | Taiwan | 2 | |
#8 | Argentina | 1 | |
#9 | Brazil | 1 | |
#10 | Israel | 1 | |
#11 | Republic of Korea | 1 | |
#12 | Philippines | 1 | |
#13 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Heterocyclic compounds | |
#3 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Vacca Joseph | 26 |
#2 | Mccomas Casey Cameron | 23 |
#3 | Castro Alfredo C | 23 |
#4 | Maclay Tyler | 18 |
#5 | Day Melinda | 5 |
#6 | Mills Kevin | 5 |
#7 | Lapierre Jean-Marc | 2 |
#8 | Alfredo C Castro | 1 |
#9 | Joseph Vacca | 1 |
#10 | Mccomas Casey | 1 |
Publication | Filing date | Title |
---|---|---|
US2020397760A1 | Methods of using rad51 inhibitors for treatment of pancreatic cancer | |
WO2020198298A1 | Combinations of rad51 and parp inhibitors | |
US2020291014A1 | Rad51 inhibitors | |
EP3681884A1 | Rad51 inhibitors | |
US2020129484A1 | Rad51 inhibitors |